Initiation of enzyme replacement therapy for an adult patient with asymptomatic type 1 Gaucher's disease

Internal Medicine

Volumn 40, Issue 8, 2001, Pages 716-721

  Tanaka, Naoki ^a,b   Saito, Hiroshi ^a   Ito, Toshiro ^a   Momose, Kayoko ^a,b   Ishida, Fumihiro ^a,b   Hora, Kazuhiko ^b   Kiyosawa, Kendo ^b   Ida, Hiroyuki ^c  

^a NAGANO RED CROSS HOSPITAL   (Japan)

^b SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

1448C (L444P) mutation; Bone involvement; Enzyme replacement therapy; MRI

Indexed keywords

ALGLUCERASE; GLUCOSYLCERAMIDASE; IMIGLUCERASE;

ADULT; ARTICLE; BONE MARROW EXAMINATION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; ENZYME REPLACEMENT; FEMALE; GAUCHER DISEASE; GENE MUTATION; HEPATOSPLENOMEGALY; HUMAN; HUMAN CELL; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; SKIN FIBROBLAST; THROMBOCYTOPENIA;

EID: 0034859386     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.40.716     Document Type: Article

References (22)

1. Brady RO, Kanifer JN, Shapiro D. Metabolism of glucocerebrosides. II. Evidence of an enzymatic deficiency in Gaucher's disease. Biochem Biophys Res Commun 18: 221-225, 1965.
2. Beutler E, Grabowski G. Gaucher diease. in: The Metabolic Basis of Inherited Disease. 7th ed. Scriver CR, Beaudet AL, Sly WS, Valle D, Eds. McGraw-Hill, New York, 1995: 2641-2670.
3. Ginns EI, Choudary PV, Tsuji S, et al. Gene mapping and leader polypeptide sequence of human glucocerebrosidase: implications for Gaucher disease. Proc Natl Acad Sci USA 82: 7101-7105, 1985.
4. Horowitz M, Zimran A. Mutations causing Gaucher disease. Hum Mutat 3: 1-11, 1994.
5. Beutler E, Gelbart T. Glucocerebrosidase (Gaucher disease). Hum Mutat 8: 207-213, 1996.
6. Ida H, Rennert OM, Kawame H, Maekawa K, Eto Y. Mutation prevalence among 47 unrelated Japanese patients with Gaucher disease: identification of four novel mutations. J Inherit Metab Dis 20: 67-73, 1997.
7. Beutler E, Kay A, Saven A, et al. Enzyme replacement therapy for Gaucher disease. Blood 78: 1183-1189, 1991.
8. Rosenthal DI, Doppelt SH, Mankin HJ, et al. Enzyme replacement therapy for Gaucher disease: skeletal responses to macrophage-targeted glucocerebrosidase. Pediatrics 96: 629-637, 1995.
9. Charrow J, Esplin JA, Gribble TJ, et al. Gaucher disease: recommendations on diagnosis, evaluation, and monitoring. Arch Intern Med 158: 1754-1760, 1998.
10. Patterson MC, Horowitz M, Abel RB, et al. Isolated horizontal supranuclear gaze palsy as a marker of severe systemic involvement in Gaucher's disease. Neurology 43: 1993-1997, 1993.
11. Beutler E. Gaucher disease: new molecular approaches to diagnosis and treatment. Science 256: 794-799, 1992.
12. Ida H, Iwasawa K, Kawame H, Rennert OM, Maekawa K, Eto Y. Characteristics of gene mutations among 32 unrelated Japanese Gaucher disease patients: absence of the common Jewish 84GG and 1226G mutations. Hum Genet 95: 717-720, 1995.
13. Zimran A, Sorge J, Gross E, Kubitz M, West C, Beutler E. Prediction of severity of Gaucher's disease by identification of mutations at DNA level. Lancet 2: 349-352, 1989.
14. Ida H, Rennert OM, Ito T, Maekawa K, Eto Y. Type 1 Gaucher disease: phenotypic expression and natural history in Japanese patients. Blood Cell Mol Dis 24: 73-81, 1998.
15. Ida H, Rennert OM, Kato S, et al. Severe skeletal complications in Japanese patients with type 1 Gaucher disease. J Inherit Metab Dis 22: 63-73, 1999.
16. Rosenthal DI, Scott JA, Barranger J, et al. Evaluation of Gaucher disease using magnetic resonance imaging. J Bone Joint Surg [Am] 68: 802-808, 1986.
17. Terk MR, Esplin J, Lee K, Magre G, Colletti PM. MR imaging of patients with type 1 Gaucher's disease: relationship between bone and visceral changes. Am J Roentgenol 165: 599-604, 1995.
18. Sibille A, Eng CM, Kim SJ, Pastores G, Grabowski GA. Phenotype/geno-type correlations in Gaucher disease type I: clinical and therapeutic implications. Am J Hum Genet 52: 1094-1101, 1993.
19. Grace ME, Newman KM, Scheinker V, Berg-Fussman A, Grabowski GA. Analysis of human acid β-glucosidase by site-directed mutagenesis and heterologous expression. J Biol Chem 269: 2283-2291, 1994.
20. Tsuji S, Choudary PV, Martin BM, et al. A mutation in the human glucocerebrosidase gene in neuronopathic Gaucher's disease. N Engl J Med 316: 570-575, 1987.
21. Theophilus BD, Latham T, Grabowski GA, Smith FI. Comparison of RNase A, a chemical cleavage and GC-clamped denaturing gradient gel electrophoresis for the detection of mutations in exon 9 of the human acid β-glucosidase gene. Nucleic Acids Res 17: 7707-7722, 1989.
22. Hermann G, Pastores GM, Abdelwahab IF, Lorberboym AM. Gaucher disease: assessment of skeletal involvement and therapeutic responses to enzyme replacement. Skeletal Radiol 26: 687-696, 1997.